Definitive Contract 140D0426C0009
Award Date 3/2/26
Potential Completion Date 9/1/27
Potential Value $600K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Friendswood, TX 77546, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Celartia, Inc., a small disadvantaged business, for the development of a fully automated system for cell therapy processing. The contract has a period of performance from September 13, 2021 to June 12, 2022 and a ceiling value of $393,312. The contract was awarded under a total small business set-aside. The original...
- This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
- This is a $4,099,969.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) to Calyx Systems LLC, a small business. The contract is for the development of a "BioSmart" implantable cardiovascular monitoring device under the ARPA-H SBIR program. The device will have electrochemical monitoring, acoustics, power recovery, and wireless telemetry capabilities. This contract was set aside for small businesses and is part of a larger SBIR solicitation that includes...
- This is a $4,091,483 Firm Fixed Price Definitive Contract awarded by the National Institutes of Health (NIH) to Feromics Inc., a small business located in Brookline, Massachusetts. The contract is part of the Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR) program and is set aside for total small businesses. The contract is for research and development to advance ARPA-H's mission and SBIR program objectives. Specific topic areas include...
- This federal contract award, valued at $400,000.00, was issued by the National Cancer Institute (NCI) to Elate Medical, Inc., a small business located in Houston, Texas. The contract is for the Small Business Innovation Research (SBIR) Phase I effort under Topic 445 - "Advanced Manufacturing to Speed Availability of Emerging Autologous Cell-based Therapies". The ultimate completion date for this Firm Fixed Price contract is September 14, 2023. This SBIR contract opportunity was...
- This SBIR Phase I contract was awarded by the National Institutes of Health's National Cancer Institute to Cellfe Inc. for $358,930. The contract is for the period of September 8, 2020 through June 7, 2021 and involves research and development of a microfluidic transfection platform for rapid manufacturing of mRNA CAR lymphocyte products. The solicitation sought proposals to conduct R&D in support of NIH and CDC agency missions, including alternatives to cell culture materials and cancer...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Heart Lung and Blood Institute to Alphathera, a self-certified small disadvantaged business. The contract is for the development of reagents for small cell number ChIC-seq, which is a technology for analyzing protein-DNA interactions. The contract has a potential value of $150,000 and is a firm-fixed-price definitive contract. The original solicitation was part of...
- The National Institutes of Health awarded a $600,000 firm fixed-price contract to Quantitative Biosciences, Inc., a San Diego-based small business, for cell and gene therapy process analytical technology and quality control testing. The contract was awarded on February 26, 2026, with an ultimate completion date of March 31, 2027, under a total small business set-aside designation. This effort supports the NIH's mission to advance biomedical research by developing critical analytical and...
- <p>This is a Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Protein Foundry, LLC, a small business, for the "Therapeutic Delivery of ADP-Ribosylarginine Hydrolase, SBIR Topic 91, Phase I" with a ceiling value of $250,000.00. The contract has a total small business set-aside designation. The contract was awarded on September 15, 2015 and is set to be completed by March 14, 2017.</p>
- This is a $1,648,645.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc. under the Small Business Innovation Research (SBIR) Phase II program. The purpose of this contract is to focus on developing a T-cell activation protocol consistent with reporter cell viability, creating a proprietary reporter cell line, and gathering and benchmarking...